Flutrimazole, a novel imidazole antifungal launched in Spain, is indicated for mycosis of the skin. Flutrimazole displays potent broad-spectrum of
activity against dematophytes, filamentous fungi and yeasts, saprophytic and
pathogenic to animals and humans. Similar to other imidazole and triazole antifungals,
flutrimazole exerts its biological function through inhibition of fungal lanosterol 14a-demethylase. Excellent local and systemic tolerance of flutrimazole in patients has been reported.
White or almost white powder.
Flutrimazole is a new imidazole antifungal agent with anti-inflammatory properties as well.
ChEBI: An imidazole antifungal agent that is imidazole in which the hydrogen attached to the nitrogen is replaced by a 2,4'-difluorotrityl group. A topical antifungal agent which displays potent broad-spectrum in vitro activity against dermatophytes,
filamentous fungi and yeasts.
